MHRP

Featured Research Trials

RV144 Vaccine Trial

Thai Study First to Show Some Effectiveness in Preventing HIV

An Army-sponsored phase III clinical trial (RV144) involving more than 16,000 adult volunteers in Thailand showed that an investigational HIV vaccine regimen was safe and modestly effective in preventing HIV infection.

more about the trial


  • RV217: A multi-site research study on acute HIV infections

  • RV254: An early HIV infection study in Thailand

  • RV262: Phase I study to evaluate a combination DNA prime/MVA vector boost vaccine regimen

  • RV305: Immunogenicity study evaluating extended boosting regimens using the same vaccine components used in RV144

  • RV306: Clinical study using RV144 vaccine regimen to compare additional vaccine boosts in 360 new volunteers
  • RV329: African Cohort Study

 

more about all current research trials

News & Updates

MHRP International Network

Nigeria, Kenya, Tanzania, Uganda,
Thailand, U.S., Mozambique

Voices from the Field

Voices from the Field

PEPFAR's Impact After 10 Years


Launched in 2003, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest effort by any nation to combat a single disease. Meet Joyline. She is here today because of PEPFAR. Born with HIV, she was brought to the Walter Reed Program in Kenya in 2004 very ill and small for her age. Today, Joyline is preparing to attend college.

see more

In the Spotlight

Video: Early HIV Infection Study Offers Insight Into the Initial Stages of HIV Infection

MHRP researchers and Thai collaborators are leading the way in acute infection studies. One study, called RV254/SEARCH 010 is providing knowledge about the earliest HIV events that may provide clues to developing an effective HIV vaccine or even help identify ways to achieve a functional cure.

see more

HIV Diagnostics & Reference Laboratory

MHRP oversees all HIV testing for the Army and serves as the Tri-Service Reference Laboratory.

see more

HJF